Search for: "SmithKline Beecham Corp. v. Abbott Laboratories"
Results 1 - 20
of 28
Sorted by Relevance
|
Sort by Date
15 Aug 2013, 9:01 pm
One such setting is raised by an interesting and important case, Smithkline Beecham Corp. v. [read post]
17 Feb 2010, 4:55 pm
District Court for the Northern District of California denied defendant Abbott Laboratories' motion to dismiss predatory pricing and refusal to deal claims set forth in the second amended complaints filed by Direct Purchasers and Abbott's competitor, SmithKline Beecham Corp. [read post]
11 Feb 2014, 8:01 am
The attorney general told the court:After thoughtful review and analysis, the state has determined that its arguments grounded upon equal protection and due process are no longer sustainable.Nevada's Governor Brian Sandoval agrees with the attorney general.As described by SCOTUSblog, the state changed its position after considering the 9th Circuit's decision last month in SmithKline Beecham Corp. v. [read post]
16 Aug 2013, 6:25 am
Here is link to all of the briefs in the Smithkline Beecham Corp. v. [read post]
26 Jun 2014, 4:00 am
In SmithKline Beecham Corp. v. [read post]
13 Feb 2014, 9:01 pm
In Part One of this series, we began to analyze the recent decision from the federal Ninth Circuit Court of Appeals in SmithKline Beecham Corp. v. [read post]
5 Dec 2011, 8:59 am
SmithKline Beecham Corp., for example, rejected the argument that pharmaceutical sales representatives did not qualify for the Outside Sales exemption. [read post]
27 Mar 2014, 2:40 pm
This development in the Ninth Circuit case of SmithKline Beecham Corp. v. [read post]
5 Dec 2011, 8:59 am
SmithKline Beecham Corp., for example, rejected the argument that pharmaceutical sales representatives did not qualify for the Outside Sales exemption. [read post]
17 Apr 2014, 9:28 pm
The case of SmithKline Beecham Corp. v. [read post]
30 Jan 2014, 9:01 pm
In SmithKline Beecham Corp. v. [read post]
5 May 2010, 4:46 am
-Florida et al.; and Abbott Laboratories et al. v. [read post]
6 Aug 2009, 6:50 am
SmithKline Beecham Corp., 2008 WL 2491965, at *7 (S.D. [read post]
25 Jan 2014, 4:44 pm
” The panel decision came in the case of SmithKline Beecham Corp. v. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks… [read post]
5 Jun 2015, 6:40 am
See Smithkline Beecham Corp. v. [read post]
8 Mar 2011, 1:23 pm
Cir. 2006) (en banc in part) SmithKline Beecham Corp. v. [read post]
16 Apr 2013, 6:51 am
Smithkline Beecham Corp., 658 N.W.2d 127 (Mich. 2003)) that ultimately face-planted that non-severability claim.Here they go again – even though the statute contains an express severability clause:If any provision of this Act or its application to any person or circumstance is held invalid, the invalidity does not affect other provisions or applications of this Act that can be given effect without the invalid provision or application, and to this end the provisions… [read post]
7 Nov 2014, 5:52 am
Novartis Pharmaceuticals Corp., 952 F. [read post]
13 May 2010, 12:27 pm
SmithKline Beecham Corp., 2008 WL 2491965 (S.D. [read post]
